Transfemoral hepatic vein catheterization reduces procedure time in double vein embolization.
Double vein embolization
Hepatic vein embolization
Journal
CVIR endovascular
ISSN: 2520-8934
Titre abrégé: CVIR Endovasc
Pays: Switzerland
ID NLM: 101738484
Informations de publication
Date de publication:
22 May 2024
22 May 2024
Historique:
received:
24
03
2024
accepted:
16
05
2024
medline:
22
5
2024
pubmed:
22
5
2024
entrez:
22
5
2024
Statut:
epublish
Résumé
Double vein embolization with simultaneous embolization of the portal and hepatic vein aims to grow the future liver remnant in preparation for major hepatectomy. Transvenous hepatic vein embolization is usually done via a transjugular access. The purpose of this study is to describe the transfemoral approach as an alternative option and to discuss potential advantages. Twenty-three patients undergoing hepatic vein embolization via a transjugular (n = 10) or transfemoral access (n = 13) were evaluated retrospectively. In all cases the portal vein embolization was done first. All procedures were technically successful. There were no peri-interventional complications. Only two patients were not able to proceed to surgery. Standardized future liver remnant hypertrophy was non-inferior with the transfemoral approach compared to the transjugular route. Procedure time was significantly shorter in the transfemoral access group (40 ± 13 min) compared to the transjugular group (67 ± 13 min, p < 0.001). Transfemoral hepatic vein embolization is feasible, safe, and faster due to easier catheterization, improved stability, and simpler patient preparation. These findings will need to be validated in larger studies.
Sections du résumé
BACKGROUND
BACKGROUND
Double vein embolization with simultaneous embolization of the portal and hepatic vein aims to grow the future liver remnant in preparation for major hepatectomy. Transvenous hepatic vein embolization is usually done via a transjugular access. The purpose of this study is to describe the transfemoral approach as an alternative option and to discuss potential advantages.
RESULTS
RESULTS
Twenty-three patients undergoing hepatic vein embolization via a transjugular (n = 10) or transfemoral access (n = 13) were evaluated retrospectively. In all cases the portal vein embolization was done first. All procedures were technically successful. There were no peri-interventional complications. Only two patients were not able to proceed to surgery. Standardized future liver remnant hypertrophy was non-inferior with the transfemoral approach compared to the transjugular route. Procedure time was significantly shorter in the transfemoral access group (40 ± 13 min) compared to the transjugular group (67 ± 13 min, p < 0.001).
CONCLUSION
CONCLUSIONS
Transfemoral hepatic vein embolization is feasible, safe, and faster due to easier catheterization, improved stability, and simpler patient preparation. These findings will need to be validated in larger studies.
Identifiants
pubmed: 38776033
doi: 10.1186/s42155-024-00463-5
pii: 10.1186/s42155-024-00463-5
doi:
Types de publication
Journal Article
Langues
eng
Pagination
49Informations de copyright
© 2024. The Author(s).
Références
Esposito F, Lim C, Lahat E, et al. Combined hepatic and portal vein embolization as preparation for major hepatectomy: a systematic review. HPB. 2019;21:1099–106. https://doi.org/10.1016/j.hpb.2019.02.023 .
doi: 10.1016/j.hpb.2019.02.023
pubmed: 30926329
Kobayashi K, Yamaguchi T, Denys A, et al. Liver venous deprivation compared to portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: a single center experience. Surgery. 2020;167:917–23. https://doi.org/10.1016/j.surg.2019.12.006 .
doi: 10.1016/j.surg.2019.12.006
pubmed: 32014304
Laurent C, Fernandez B, Marichez A, et al. Radiological simultaneous portohepatic vein embolization (RASPE) before major hepatectomy: a better way to optimize liver hypertrophy compared to portal vein embolization. Ann Surg. 2020;272:199–205. https://doi.org/10.1097/SLA.0000000000003905 .
doi: 10.1097/SLA.0000000000003905
pubmed: 32675481
Le Roy B, Gallon A, Cauchy F, et al. Combined biembolization induces higher hypertrophy than portal vein embolization before major liver resection. HPB. 2020;22:298–305. https://doi.org/10.1016/j.hpb.2019.08.005 .
doi: 10.1016/j.hpb.2019.08.005
pubmed: 31481315
Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol. 2016;26:4259–67. https://doi.org/10.1007/s00330-016-4291-9 .
doi: 10.1007/s00330-016-4291-9
pubmed: 27090112
Guiu B, Quenet F, Escal L, et al. Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function. Eur Radiol. 2017;27:3343–52. https://doi.org/10.1007/s00330-017-4744-9 .
doi: 10.1007/s00330-017-4744-9
pubmed: 28101681
Najafi A, Schadde E, Binkert CA. Combined simultaneous embolization of the portal vein and hepatic vein (double vein embolization) – a technical note about embolization sequence. CVIR Endovasc. 2021;4:43. https://doi.org/10.1186/s42155-021-00230-w .
doi: 10.1186/s42155-021-00230-w
pubmed: 34037882
pmcid: 8155155
Della Corte A, Santangelo D, Augello L, et al. Single-center retrospective study comparing double vein embolization via a trans-jugular approach with liver venous deprivation via a trans-hepatic approach. Cardiovasc Intervent Radiol. 2023. https://doi.org/10.1007/s00270-023-03538-3 .
doi: 10.1007/s00270-023-03538-3
pubmed: 37704862
Ribero D, Chun Y, Vauthey J-N. Standardized liver volumetry for portal vein embolization. Semin Intervent Radiol. 2008;25:104–9. https://doi.org/10.1055/s-2008-1076681 .
doi: 10.1055/s-2008-1076681
pubmed: 21326551
pmcid: 3036478
Vauthey J. Body surface area and body weight predict total liver volume in western adults. Liver Transpl. 2002;8:233–40. https://doi.org/10.1053/jlts.2002.31654 .
doi: 10.1053/jlts.2002.31654
pubmed: 11910568